Aerie Pharmaceuticals (AERI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -232,569 | -181,111 | -95,723 | -40,699 | -145,105 |
| Depreciation Amortization | 4,088 | 2,563 | 1,281 | 465 | 1,725 |
| Accounts receivable | -2,715 | -1,961 | -1,125 | N/A | N/A |
| Accounts payable and accrued liabilities | 26,583 | 10,924 | 3,004 | -6,873 | 925 |
| Other Working Capital | 13,388 | 4,619 | -2,229 | -9,470 | -1,314 |
| Other Operating Activity | 38,649 | 43,904 | 16,993 | 15,742 | 50,556 |
| Operating Cash Flow | $-152,576 | $-121,062 | $-77,799 | $-40,835 | $-93,213 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -31,313 | -29,404 | -23,032 | -9,126 | -15,970 |
| Purchase Of Investment | -56,195 | -56,195 | -56,195 | -56,195 | -104,490 |
| Sale Of Investment | 108,297 | 107,297 | 92,827 | 23,775 | 88,153 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -10,500 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -10,500 |
| Investing Cash Flow | $20,789 | $21,698 | $13,600 | $-41,546 | $-42,807 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 139,602 | 138,905 | 135,972 | 135,972 | 135,644 |
| Other Financing Activity | -2,566 | -2,156 | 1,306 | -1,659 | 0 |
| Financing Cash Flow | $137,036 | $136,749 | $137,278 | $134,313 | $135,644 |
| Beginning Cash Position | 197,569 | 197,569 | 197,569 | 197,569 | 197,945 |
| End Cash Position | 202,818 | 234,954 | 270,648 | 249,501 | 197,569 |
| Net Cash Flow | $5,249 | $37,385 | $73,079 | $51,932 | $-376 |
| Free Cash Flow | |||||
| Operating Cash Flow | -152,576 | -121,062 | -77,799 | -40,835 | -93,213 |
| Capital Expenditure | -31,313 | -29,404 | -23,032 | -9,126 | -15,970 |
| Free Cash Flow | -183,889 | -150,466 | -100,831 | -49,961 | -109,183 |